Natural Killer (NK) Cell Therapy Pipeline Research Report 2024: Comprehensive Insights About 100+ Companies and 185+ Pipeline Drugs
April 19, 2024 07:35 ET
|
Research and Markets
Dublin, April 19, 2024 (GLOBE NEWSWIRE) -- The "Natural Killer (NK) cell therapy - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This "Natural Killer...
Global Flow Cytometry Markets Analysis/Research Report 2023: Immuno-Oncology Frontier and Liquid Biopsy Combine to Create Enormous Market Demand - Forecasts to 2028
January 13, 2023 04:58 ET
|
Research and Markets
Dublin, Jan. 13, 2023 (GLOBE NEWSWIRE) -- The "Flow Cytometry Markets: Forecasts by Technology, Product and Application, with Executive and Consultant Guides and Including Customized Forecasting"...
Outlook on the Flow Cytometry Global Market to 2025 - Move to Cell Based Analytics is Driving Growth
April 27, 2022 05:03 ET
|
Research and Markets
Dublin, April 27, 2022 (GLOBE NEWSWIRE) -- The "Flow Cytometry Global Market to 2025" report has been added to ResearchAndMarkets.com's offering. Flow Cytometry is a mainstay of analytical methods...
Global Flow Cytometry Markets, 2022-2027 by Technology, Product and Application, with Executive and Consultant Guides
March 04, 2022 04:18 ET
|
Research and Markets
Dublin, March 04, 2022 (GLOBE NEWSWIRE) -- The "Flow Cytometry Markets: Forecasts by Technology, Product and Application, with Executive and Consultant Guides and Including Customized Forecasting"...
Global Flow Cytometry Market Report 2021-2025 - Immuno-Oncology Frontier and Liquid Biopsy Combine to Create Enormous Market Demand
November 24, 2021 04:23 ET
|
Research and Markets
Dublin, Nov. 24, 2021 (GLOBE NEWSWIRE) -- The "Flow Cytometry Markets: Forecasts by Technology, Product and Application, with Executive and Consultant Guides and Including Customized Forecasting -...
Cocrystal Pharma Provides Update on its COVID-19 Antiviral Discovery and Development Programs
May 03, 2021 08:00 ET
|
Cocrystal Pharma, Inc.
BOTHELL, Wash., May 03, 2021 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP), (“Cocrystal” or the “Company”), a clinical-stage biotechnology company discovering and developing novel...
Global Cell-Based Assays Markets, 2020-2025: Growing Preference for Cell-Based Assays in Drug Discovery & Increasing Funding for Cell-Based Research
April 01, 2021 07:58 ET
|
Research and Markets
Dublin, April 01, 2021 (GLOBE NEWSWIRE) -- The "Cell-Based Assays Market by Product & Service (Reagents, Microplate, Cell Lines, Assay Kits, Instrument & Software, Services), Application...
In-Vitro Toxicology/Toxicity Testing Market Worth $14.4 Billion by 2025, Growing at a CAGR of 9% from 2019- Global Opportunity Analysis and Industry Forecasts by Meticulous Research®
June 23, 2020 13:45 ET
|
Meticulous Market Research Pvt. Ltd.
London, June 23, 2020 (GLOBE NEWSWIRE) -- Safety assessment of substances is essential to determine their toxic implications on humans and the environment. Toxicology studies evaluate the substances...
Cocrystal Pharma Reports 2018 Third Quarter Financial Results and Provides Corporate Update
November 12, 2018 08:00 ET
|
Cocrystal Pharma, Inc.
BOTHELL, WA, Nov. 12, 2018 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (NASDAQ: COCP), (“Cocrystal” or the “Company”), a clinical stage biotechnology company discovering and developing novel...